* Clover Health Investments Corp CLOV.OQ CLOV.O is
expected
to show a rise in quarterly revenue when it reports results on
February 28.
* The Franklin Tennessee-based company is expected to
report a
81.8% increase in revenue to $785.379 million from $432.04
million a year ago, according to the mean estimate from 5
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Clover Health
Investments
Corp is for a loss of 26 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and 2 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Clover
Health
Investments Corp is $1.63, above its last closing price
of $1.14.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 -0.25 -0.24 -0.16 Beat 33.1
Jun. 30 2022 -0.21 -0.21 -0.22 Missed -6.7
Mar. 31 2022 -0.28 -0.27 -0.19 Beat 30.5
Dec. 31 2021 -0.27 -0.26 -0.28 Missed -7.9
Sep. -0.24 -0.23 -0.08 Beat 65
30 2021
Jun. 30 2021 -0.13 -0.14 -0.78 Missed -476.4
Mar. 31 2021 -0.11 -0.11 -0.13 Missed -17.5
Dec. 31 2020 -0.84
This summary was machine generated February 24 at 19:34 GMT.
All figures in US dollars unless otherwise stated